chrisvoncsefalvay/vaers-outcomes huggingface dataset:
AFTER 1ST VACCINE SEVERE HEADACHE FOR DAYS...WENT TO DOCTOR AND DAY 10 AND MEDICINE FOR RELIEF DIZZY BRAIN FOG FEVER BODY ACHES CHILLS FATIGUE SORE AT INJECTION SITE  AFTER 2ND VACCINE: EXTREME HEADACHES, HAVE HAD THESE ALMOST EVERY DAY SINCE VACCINE DIZZINESS-STILL CONTINUES BRAIN FOG-STILL CONTINUES EXTRENE CHILLS AND SHAKING BODY ACHES FEVER FATIGUE PAIN AT INJECTION SITE
Cellulitis at vaccine site 15 x 6.5 cm area of erythema/induration/warmth/pain.
When I picked my son up at daycare he looked a little different, we drove to Connecticut and then I noticed that the right side of his face was paralyzed. I took him to the ER they said Bell's Palsy but they weren't sure why. His Lyme test came back negative, told us to go home and follow up with his PCP. the PCP sent us to see neurology and now it has been a month and he has some kind of mass growing in his face. Now we have to go through an MRI and biopsy.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2009, the patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On an unknown date in 2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
On February 26, 2022 at waking around 07:00AM I felt something wasn't right. I had complete and total loss of hearing of my left ear. I tried something OTL called Dry Box, I am not sure what it's called but I was thinking maybe it was build-up of ear wax. It did not clear up in a few days so I called my doctors and set up a hearing test in early March. I was prescribed a course of Prednisone. I did that course of Prednisone and had an MRI before the next follow-up and second hearing test on March 24, 2022. MRI of the brain and It came back normal. I did do a little better but I maybe got about 30% hearing back. But at that time they wanted to do injections into my eardrum of steroids but I did some research and did not feel I wanted to do that. I had a test done on my eardrum which was part of the Audiology hearing test which was normal. Both of my eardrums were functioning fine. I still have just 30% hearing and my doctors are suggesting a hearing aid or implant but I am waiting to see if it will improve over time. I feel that if I have to have anything I prefer hearing aid. This has been pretty disruptive to my life. I can no longer do a proper job being an Umpire for the softball that I have been doing for the last ten years.
chills, fever, nausea, vomiting, flank pain, myalgias, dizziness
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 58 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Known allergies: aspirin, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti-viral details: Product: COVID 19 Treatment Brand: Paxlovid from 18Oct2022 to 22Oct2022. No other medication in 2 weeks  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial report was received on 18 January 2011 from a health care professional.  This case represents one of a cluster of 4 patients from the same reporter, same vaccine, same lot number, and who experienced adverse events requiring emergency room visits after receiving FLUZONE HIGH-DOSE No Preservative 2010-2011 on different dates.  One patient was hospitalized.  Information regarding the patient who was hospitalized is reported in case number 2010-01674; and information regarding the last 2 patients are reported in cases 2011-00303 , and 2011-00252.  A 71-year-old female patient had received an intramuscular left deltoid injection of FLUZONE HIGH-DOSE No Preservative 2010-2011 (lot number U3605BA) on 25 October 2010.  That evening after receiving the vaccination, the patient experienced a productive cough with yellowish thick phlegm.  She had bruising on the left side of her ribs, which the patient felt was due to coughing.  It was not mentioned that the patient required an emergency room visit, however the patient was seen in the clinic 1 week later on 02 November 2011 and was treated with antibiotics for bronchitis.  Past medical history includes: actinic keratosis, atrial fibrillation, chronic systolic CHF (congestive heart failure), nocturnal leg cramps, DJD (degenerative joint disease) of the knee, hypothyroidism, glossopharyngeal neuralgia, obesity, osteopenia, allergic rhinitis (NDS), "spells" (Not specified), vitamin B12 deficiency, and is positive for long term use of anticoagulants and high risk medication.  Concurrent medications at time of vaccination included: Lanoxin, Levothyroxine, Metoprolol, Omeprazole, Sertraline, and warfarin.  Per the reporter, it is unknown if the patient recovered.  Documents held by sender: None.
Induced seizures in each of them; they are epileptic; now they are epileptic; There is some correlation between the diagnosis of epilepsy, their medications (Unspecified Medications), the vaccine (Pfizer Covid-19 Vaccine); had seizuresas a result; This is a spontaneous report from a contactable consumer (patient's mother)   A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: EW0162) as SINGLE DOSE for covid-19 immunisation  . The patient recevied the first dose of the same vaccine on 10Apr2021 (Lot#EN6205). Medical history included brain injury from an unknown date and unknown if ongoing Verbatim: Brain damage  , Respiratory compromise from an unknown date and unknown if ongoing Verbatim: Respiratory compromise , Prematurity  from an unknown date and unknown if ongoing Verbatim: Prematurity , Cognitive impairment from an unknown date and unknown if ongoing Verbatim: Cognitive impairment , Legally blind  from an unknown date and unknown if ongoing and Many disabilities   from an unknown date and unknown if ongoing .The patient's concomitant medications were not reported.  Reporter stated, "I am actually just trying to report some side effects that I have heard and wanted to make sure you all have the information not actually for myself particularly, my reactions were fine. But I do have with me two adult daughters. And they have some different medical ailments, disability medications and it seems though there may be reactions in both of them within 24 hours induced seizures in each of them and now they are epileptic. But they have not had a breakthrough seizures in years and so, I thought maybe there is some correlation between the diagnosis of epilepsy, their medications (Unspecified Medications) and the vaccine (Pfizer Covid-19 Vaccine) they got. After second dose two of my daughters with special needs which are having a medical condition and had seizures as a result. I am calling to make sure that Pfizer has the information documented directly because I have not heard that in any shape or form there was a seizure associated with response after the vaccine.".When paraphrased the concern, Reporter stated, "Yeah both of them, experience the seizure once within about 4 hours and then the next within I say 12 to 18 hours". .; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021422134 Same reporter/diff patient;US-PFIZER INC-2021422193 Same reporter/diff patient
Within 10 min of vaccination, pt began to experience itchy arm neck, cheeks and scalp. No SOB but due to extreme allergic reaction went to ER for IV BENADRYL and oral prednisone. 6 hrs later, itching and redness was returning. Took BENADRYL for 3 more days.
After about 7 minutes of getting the Janssen Covid-19 vaccines, patient husband said patient is not feeling well.  I attended to patient immediately.  She said she is not feeling well, and her eye was rolling (as if when she tried to look up and couldn't get their eye to remain open) a for about few seconds and then she her eye was open back to normal.  She was sweating on both hands and face were cold to the touch.  I got the manager from the store to help me lie patient flat on the floor's surface gently to prevent her from falling off the chair.    Based on this our adverse event protocol, patient exhibited similar symptoms to Syncope (paleness, sweating, coldness of extremities), so I patient is lying flat on the floor, feet elevated, and cold compression was apply on her arms and face.  Unfortunately, patient conditions was not improving as it seem but she was alert and able to breath (fast pace) the whole entire time the incident occurred where she answer all questions when we myself, then the paramedics asked her questions.  Paramedic arrived at scene within 10 minutes after individual got off the phone with 911.  They took her away around 9 am and said patient probably experience anxiety attack.
I did not have a reaction to the vaccine per se, but developed symptoms of Covid 19 on December 30, 2020 and tested positive the following day.   I had a known exposure to covid 19 several days after my shot (my son had it and we didn't know it yet).  I think I had not yet had enough time to develop immunity.     The vaccine safe person who called me said to report that on this website.  Of interest, I was a bit of a long-hauler with persistent fatigue, inability to concentrate, sleeplessness, and shortness of breath despite not having even had a cough with my covid.  I got my second shot on 1 March 2021.   I had a pretty strong immune reaction (o.k., I might have taken to my bed for three days over it) but two weeks later, I noticed a sudden change in my long-haul symptoms.  I have much improved and although I can't definitely tie it to the vaccine, there is a temporal relationship.  Thank you for reading all of this.
Systemic: Pt monitored by nursing for 30min after inj,pt was stable/no reaction.At ~1hr post inj pt was unresponsive.Pt was a hospice/dnr per director
Started having  fever chills nausea and diarrhea and felt short of breath  on 2/13.  SOB and diarrhea was better on 2/14 bug then on 2/15 pt started to feel chest pressure.  pt admitted to hospital on 2/15 noted to have NSTEMI and plt=68.  Thrombocytopenia is new for pt.  on 2/16 plt=79.  pt has been on ibrance for years for hx of breast ca- has never had thrombocytopenia related to the ibrance.
Per phone call from pt's mother: headache, shaking, hot, gen body aches. Rec'd mom's call approximately 7 hrs after vaccine administered. Pt was evaluated in our express care dept.
Interchange of vaccine products; tested positive for COVID; tested positive for COVID; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: tested positive for COVID.  Clinical course: This person had some throat clearing upon awakening from a nap today and his wife suggested that he test. He tested positive for COVID. Other than the throat clearing earlier today, he feels well and has not had any additional symptoms. He has discussed with his primary care provider. This is being reported as a positive COVID test in a person approximately 3-4 weeks s/p the Comirnaty bivalent booster vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a consumer via call center representative and described the occurrence of therapy non-responder in a female patient who received Hepatitis B vaccine. Co-suspect products included Hepatitis B vaccine and Hepatitis B vaccine. On an unknown date, the patient received the 1st dose of Hepatitis B vaccine, the 2nd dose of Hepatitis B vaccine and the 3rd dose of Hepatitis B vaccine. On an unknown date, several years after receiving Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient reported that years ago, she received the standard series of Hepatitis B vaccine (manufacturer was unknown). The titer was recently measured and the patient did not display immunity to Hepatitis B leading the patient to be a therapy non-responder. Hence, she required a booster dose. No further details were reported.
Throbbing headache, fever, joint pain to the point it was difficult to walk, nausea, swollen, sore muscles at the injection site, huge red hot welt at the injection site. All of these appeared the day following the day of the injection and lasted until nightime. (I thought about going to an UrgiCare Center because it was a Saturday and my doctor's office was closed. But I called my sister, who had the SHINGRIX vaccine the same day that I did, and she was experiencing the same symptoms so I figured it was because of the vaccine.)
Pt was given FLUMIST and has asthma. Was given on 10/2/14 and has had continuous cough and congestion along with fever since injection. Seen in our office on 10/16/14 given azithromycin tablets 250mg. Given albuterol and ROBITUSSIN AC on 10/17/14 given ZOFRAN for nausea on 10/20/14 along with prednisone 20 mg tablets.
Woke next day with very sore arm.  Nausea and diarrhea, headache and joint aches.   Similar to my reactions to all 5 COVID vaccines/ boosters.
Chills, shaking, muscle soreness starting approximately 10PM and lasting for 4-5 hours
Swollen tongue, throat, mouth, trouble breathing, red swollen itchy eyes with discharge, sore throat, shaking.
pt recv vax 25MAY98 & 7 days later 1st onset of pox vesicles-pt became more ill w/fever & more broken out;mom reports was covered in pox even in mouth & down throat;went to PMD 6JUN98 considered hosp-resolved now no secondary infect;
She got her vaccine, after dinner she noticed irritability, depression, aggravated, grumpy, yelling at the dog for doing nothing.  She does not know what she was aggravated with that.  She then noticed a large, sore itchy bump, not at injection site.  She was tired, and slight increase in temp to 99.5.  She was tired, took Tylenol and most of the symptoms went away like the grumpiness, irritability and temp went down.  The physical things stayed, the hot to touch feeling, the bump, and tenderness to touch, hard bump, very very itchy.   She tried antibiotic ointment Neosporin, then she also used Cortisone cream, which did help relieve some of the symptoms, but then would return to being itchy, and then  hot to the touch.   She does not believe it is hot to the touch.  Yesterday it was the size of a quarter and now it's down to the size of a quarter.   Yesterday a nurse who checks on her periodically called and she informed her of her reaction and she told her to report it to us.  The itchiness is gone, it does hurt a little bit when she pushes on it, but otherwise doesn't hurt.
Patient lost consciousness for a couple of minutes approximately 5 minutes after receiving vaccine. Fell to the floor hitting his head. Pharmacist had tech call 911. Patient remained on the floor lying on his belly but talking and was sweating profusely. EMS took the patient by ambulance.
18 hr after shot I experienced: Body ache, fever, vomiting,  headache, diareah
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX (lot# and route unknown) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2012, a healthcare provider at a pharmacy administered the ZOSTAVAX vaccine to the patient. In 2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
I have recurrent hives that appear on both arms but mainly surfaces on the arm of the injection. I have pictures, if requested, for review.
itching; slight little pain when the needle went in; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and VACCINATION SITE PAIN (slight little pain when the needle went in) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRURITUS (itching) and VACCINATION SITE PAIN (slight little pain when the needle went in). On 05-Feb-2021, PRURITUS (itching) had resolved. At the time of the report, VACCINATION SITE PAIN (slight little pain when the needle went in) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.    This case was linked to MOD-2021-391910 (Patient Link).
Upper arm swelling, hot and red began after a couple of hours.  Area initially the size of a grapefruit but continued to grow to cover most of upper arm. Joint pain, muscle pain, chills. Worst pain in groin area, hip socket and left leg. Stiffness. Symptoms began to subside after 40 hours. Patient is taking Tylenol.
Four to six days after the vaccine booster shot I experienced double vision 24hrs a day, both near and far. It was subsequently diagnosed by Dr. as Myasthenia Gravis. I was placed on Prednisone 5mg/day and it has stopped the double vision.
Employee received first dose of COVID19 vaccine on 8/12/2021. Employee states that on 8/13/2021 at about 7:00 am,  she started having severe headache, numbness from her left shoulder to her left foot and lower back pain of which she took Tylenol but it did not help her. She then took Advil and felt a little better.
May 8, 2021 - in addition to headaches, fatigue, dizziness. Left ear pain started at 3PM, and left cheek/face became numb. (Like novocaine wearing off)  May 9 - same symptoms as above, but left neck became numb May 13 - same symptoms as above dates persist on Day 8 post shot.
Skin rash; Skin reaction; This case was reported by a consumer via call center representative and described the occurrence of rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash and skin reaction. On an unknown date, the outcome of the rash and skin reaction were unknown.   It was unknown if the reporter considered the rash and skin reaction to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The reporter stated that patient had a skin rash after receiving the vaccine. No other information was able to be obtained. The reporter did not consent to follow up. This case has been linked to US2020006493, reported by the same reporter.
Pleuritic chest pain lasting for 2 weeks. Started 5 days after second vaccine dose. Pain with inhalation, resolving after a few minutes. Occurring randomly throughout the day, including at rest.  4/10 stabbing pain located in the center of the chest.  Worse with deep breathing. No fever, palpitations, loss of consciousness, cough, shortness of breath.  ROS was otherwise negative. No illnesses preceding event. Resolved spontaneously. Saw PCP for annual physical, at the end of May at which time the pain had already subsided. Was referred to pediatric cardiology for further evaluation.